Skip to Main Content

Paper Details

Dolutegravir Monotherapy of Simian Immunodeficiency Virus-Infected Macaques Selects for Several Patterns of Resistance Mutations with Variable Virological Outcomes.
J Virol
11
2019
DTG, Dolutegravir, E92Q, G118R, G140A/, HIV, HIV-1, HIV-infected, Macaques, Q148K, RNA copies, SIV, SIVmac251, Simian Immunodeficiency Virus, dolutegravir, drug, human immunodeficiency virus, integrase, people, persons, plasma, rhesus macaque, simian immunodeficiency virus
Author NameAffiliation
Brandon F KeeleFrederick National Laboratory for Cancer Research
Jeffrey D LifsonFrederick National Laboratory for Cancer Research
  • 1 - 2

Datasets

Release 1.2